Daniel Lu

Daniel Lu has extensive work experience in the field of biosciences. Daniel is currently working at InterVenn Biosciences as a Senior Clinical Research Associate since January 2022. Prior to this role, they held the position of Clinical Research Associate at InterVenn Biosciences from September 2020 to December 2021.

Before joining InterVenn Biosciences, Daniel worked at Biovalence Sdn. Bhd. from 2014 to 2019. During their tenure, they served as the Companion Animals Project Manager, where they were responsible for companion animal-related product research and development for therapeutics and health supplements. Daniel also handled business planning for US/EU commercialization, including market research, financial projections, risk assessment, and regulatory landscape. Additionally, they were involved in pet supplement development for Asia, covering formulation and packaging design, test protocol, market and regulatory research, manufacturing and QC/QA processes, and profit and cost analysis.

Prior to their role as the Companion Animals Project Manager, Daniel worked as an Animal Trial Executive/Research Associate at Biovalence Sdn. Bhd., where they conducted preclinical studies in rodents, including pharmacokinetic and toxicology studies. Daniel also gained experience in raising, harvesting, and validating polyclonal antibodies in rodents, as well as ELISA optimization and detection/quantification of protein drugs and anti-drug antibodies.

Daniel's earliest role at Biovalence Sdn. Bhd. was as an Animal Field Trial Coordinator, where they coordinated field trials related to animal research.

Overall, Daniel Lu's work experience highlights their expertise in clinical research, project management, market and regulatory research, and preclinical studies in the biosciences industry.

Daniel Lu attended the University of Melbourne, though no specific degree program or field of study is mentioned. No information regarding the start or end year of their education at the university was provided.